About Equine Healthcare
Equine health refers to veterinary services intended to treat horses to enhance their quality of life, increase their lifespan, and develop better quality animal food. Equine diagnostic products, equine therapeutic products, and equine supplement products are the three major product types discussed in this report. Equine diagnostic products help to detect bacteria, antibodies, and viruses; equine therapeutic products include vaccination that helps treat any disease condition; and equine supplement products help in maintaining specific requirement of supplements.
TechNavio's analysts forecast the Global Equine Healthcare market to decline at a CAGR of 1.24 percent over the period 2014-2019.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Equine Healthcare market for the period 2015-2019. To calculate the market size, the report considers revenue generated through the sales of various equine healthcare products. In terms of product, the Global Equine Healthcare market can be divided into three segments: Equine Diagnostic Products, Equine Therapeutic Products, and Equine Genotype Analysis.
TechNavio's report, the Global Equine Healthcare Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Equine Healthcare market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key Regions
• Americas
• APAC
• EMEA
Key Vendors
• Affymetrix
• Bayer Health Care
• Boehringer Ingelheim
• Elanco Animal Health
• Merck Animal Health
• Purina Animal
• Zoetis
Other Prominent Vendors
• Boerhringer Ingelheim Vetmedica
• Ceva Holdings
• Merial
• Novartis Animal Health
• Signostics
• Vetoquinol
Market Driver
• Increase in Demand
• For a full, detailed list, view our report
Market Challenge
• Decrease in Global Equine Population
• For a full, detailed list, view our report
Market Trend
• Increase in Awareness
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by Products
07.1 Global Equine Vaccines Market
07.1.1 Market Size and Forecast
08. Geographical Segmentation
09. Buying Criteria
10. Market Growth Drivers
11. Drivers and their Impact
12. Market Challenges
13. Impact of Drivers and Challenges
14. Market Trends
15. Trends and their Impact
16. Vendor Landscape
16.1 Competitive Scenario
16.1.1 Key News
16.1.2 Mergers and Acquisitions
17. Market Share Analysis 2014
17.1 Affymetrix
17.2 Bayer Health Care
17.2.1 Segmentation by End-user
17.3 Boehringer Ingelheim
17.4 Elanco
17.4.1 Segmentation by End-user
17.4.2 Segmentation by Geography
17.5 Merck Animal Health
17.5.1 Segmentation by End-user
17.5.2 Segmentation by Geography
17.6 Purina Animal
17.7 Zoetis
17.7.1 Segmentation by Species Type
17.7.2 Segmentation by Product Type
17.7.3 Segmentation by Geography
17.7.4 Segmentation by Country
17.7.5 Segmentation by End-user
17.8 Other Prominent Vendors
18. Key Vendor Analysis
18.1 Affymetrix
18.1.1 Key Facts
18.1.2 Business Overview
18.1.3 Business Segmentation
18.1.4 Business Segmentation by Revenue 2013
18.1.5 Business Segmentation by Revenue 2012 and 2013
18.1.6 Sales by Geography
18.1.7 Business Strategy
18.1.8 Key Information
18.1.9 SWOT Analysis
18.2 Bayer HealthCare
18.2.1 Key Facts
18.2.2 Business Overview
18.2.3 Business Segmentation by Revenue 2013
18.2.4 Business Segmentation by Revenue 2012 and 2013
18.2.5 Geographical Segmentation by Revenue 2013
18.2.6 Business Strategy
18.2.7 Recent Developments
18.2.8 SWOT Analysis
18.3 Boehringer Ingelheim
18.3.1 Key Facts
18.3.2 Business Overview
18.3.3 Business Segmentation by Revenue 2013
18.3.4 Business Segmentation by Revenue 2012 and 2013
18.3.5 Geographical Segmentation by Revenue 2013
18.3.6 Business Strategy
18.3.7 Recent Developments
18.3.8 SWOT Analysis
18.4 Elanco Animal Health
18.4.1 Key Facts
18.4.2 Business Overview
18.4.3 Business Strategy
18.4.4 Recent Developments
18.4.5 SWOT Analysis
18.5 Merck Animal Health
18.5.1 Key Facts
18.5.2 Business Overview
18.5.3 Business Strategy
18.5.4 Recent Developments
18.5.5 SWOT Analysis
18.6 Purina
18.6.1 Key Facts
18.6.2 Business Overview
18.6.3 Key Products
18.6.4 Business Strategy
18.6.5 Recent Developments
18.6.6 SWOT Analysis
18.7 Zoetis
18.7.1 Key Facts
18.7.2 Business Overview
18.7.3 Business Segmentation by Revenue 2013
18.7.4 Business Segmentation by Revenue 2012 and 2013
18.7.5 Geographical Segmentation by Revenue 2013
18.7.6 Business Strategy
18.7.7 Recent Developments
18.7.8 SWOT Analysis
19. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Equine Healthcare Market 2014-2019 (US$ billion)
Exhibit 3: Global Equine Healthcare Market: Segmentation by Product
Exhibit 4: Global Equine Healthcare Market: Segmentation 2014
Exhibit 5: Global Equine Vaccines Market 2014-2019 (US$ billion)
Exhibit 6: Global Equine Healthcare Market by Geographical Segmentation 2014
Exhibit 7: Affymetrix Year on Year Sales Comparison 2010-2013 (US$ million)
Exhibit 8: Bayer's Revenue by Segment 2013
Exhibit 9: Bayer Animal Health: Segmentation by End-user
Exhibit 10: Eli Lilly: Revenue by Segment 2013
Exhibit 11: Elanco: Segmentation by End-user
Exhibit 12: Elanco: Revenue by Geography 2013
Exhibit 13: Merck: Revenue by Segment 2013
Exhibit 14: Merck Animal Health: Segmentation by End-user
Exhibit 15: Merck Animal Health: Segmentation by End-user
Exhibit 16: Merck Animal Health: Segmentation by Geography 2013
Exhibit 17: Land O Lakes Year on Year Sales Comparison 2010-2013 (US$ million)
Exhibit 18: Zoetis: Segmentation by Species Type
Exhibit 19: Zoetis: Revenue of Species Type Segmentation 2013
Exhibit 20: Zoetis: Segmentation by Product Type
Exhibit 21: Zoetis: Revenue of Product Type Segmentation 2013
Exhibit 22: Zoetis: Revenue of Geographical Segmentation 2013
Exhibit 23: Zoetis: Revenue Segmentation by Geography
Exhibit 24: Zoetis: Revenue of Country-wise Segmentation 2013
Exhibit 25: Zoetis: Segmentation by End-user
Exhibit 26: Zoetis: Revenue of End-user Segment 2013
Exhibit 27: Zoetis: Companion Animals Segmentation by Product Type
Exhibit 28: Zoetis: Companion Animals Segmentation by Species Type
Exhibit 29: Zoetis: Revenue of Companion Animals Segment by Species Type 2013
Exhibit 30: Zoetis: Revenue of Companion Animals Segment by Geography 2013
Exhibit 31: Affymetrix Inc.: Business Segmentation 2013
Exhibit 32: Affymetrix Inc.: Business Segmentation by Revenue 2013
Exhibit 33: Affymetrix Inc.: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 34: Affymetrix Inc.: Sales by Geography 2013
Exhibit 35: Bayer HealthCare: Business Segmentation by Revenue 2013
Exhibit 36: Bayer HealthCare: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 37: Bayer HealthCare: Geographical Segmentation by Revenue 2013
Exhibit 38: Boehringer Ingelheim: Business Segmentation by Revenue 2013
Exhibit 39: Boehringer Ingelheim: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 40: Boehringer Ingelheim: Geographical Segmentation by Revenue 2013
Exhibit 41: Purina: Key Products
Exhibit 42: Zoetis: Business Segmentation by Revenue 2013
Exhibit 43: Zoetis: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 44: Zoetis: Geographical Segmentation by Revenue 2013
